C8ORF83 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.714800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.304400E-01
Normal-vs-Stage2
4.050400E-01
Normal-vs-Stage3
5.169600E-01
Normal-vs-Stage4
1.136780E-01
Stage1-vs-Stage2
1.413960E-01
Stage1-vs-Stage3
6.532300E-02
Stage1-vs-Stage4
5.492000E-01
Stage2-vs-Stage3
1.502240E-01
Stage2-vs-Stage4
2.292500E-02
Stage3-vs-Stage4
7.369900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.838200E-01
Normal-vs-AfricanAmerican
4.787200E-01
Normal-vs-Asian
4.584400E-01
Caucasian-vs-AfricanAmerican
8.104400E-01
Caucasian-vs-Asian
8.104000E-01
AfricanAmerican-vs-Asian
9.566200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.774600E-01
Normal-vs-Female
3.753600E-01
Male-vs-Female
8.638000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.492600E-01
Normal-vs-Age(41-60Yrs)
2.313200E-01
Normal-vs-Age(61-80Yrs)
4.600600E-01
Normal-vs-Age(81-100Yrs)
4.496600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.373200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.425600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.631200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.372780E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.391400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.893600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.131000E-01
Normal-vs-Daily Drinker
5.354600E-01
Normal-vs-Weekly Drinker
7.440400E-01
Normal-vs-Occasional Drinker
2.507200E-01
Normal-vs-Social Drinker
4.206600E-01
Non Drinker-vs-Daily Drinker
9.600600E-01
Non Drinker-vs-Weekly Drinker
5.083200E-01
Non Drinker-vs-Occasional Drinker
1.263650E-01
Non Drinker-vs-Social Drinker
5.285800E-01
Daily Drinker-vs-Weekly Drinker
5.800600E-01
Daily Drinker-vs-Occasional Drinker
1.682760E-01
Daily Drinker-vs-Social Drinker
6.416800E-01
Weekly Drinker-vs-Occasional Drinker
9.585500E-02
Weekly Drinker-vs-Social Drinker
3.622600E-01
Occasional Drinker-vs-Social Drinker
4.199200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.301800E-02
Normal-vs-Grade 2
1.910460E-02
Normal-vs-Grade 3
5.036000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.266400E-01
Grade 1-vs-Grade 3
5.878000E-01
Grade 1-vs-Grade 4
7.301800E-02
Grade 2-vs-Grade 3
3.961000E-01
Grade 2-vs-Grade 4
1.910460E-02
Grade 3-vs-Grade 4
5.036000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.815400E-01
Normal-vs-NonDiabetic
3.966000E-01
Diabetic-vs-NonDiabetic
4.227400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.285400E-01
Normal-vs-NoPancreatitis
3.952600E-01
Pancreatitis-vs-NoPancreatitis
2.055500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.848400E-01
Normal-vs-N1
3.660800E-01
N0-vs-N1
5.950000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.117400E-01
Normal-vs-TP53-NonMutant
2.770400E-01
TP53-Mutant-vs-TP53-NonMutant
3.993600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
